MedPath

Norethindrone acetate

Norethindrone acetate tablets, USP Rx only

Approved
Approval ID

2f39b608-cc62-4ff0-a52a-bc3343275269

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 4, 2023

Manufacturers
FDA

Ingenus Pharmaceuticals, LLC

DUNS: 833250017

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

norethindrone acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50742-267
Application NumberANDA206490
Product Classification
M
Marketing Category
C73584
G
Generic Name
norethindrone acetate
Product Specifications
Route of AdministrationORAL
Effective DateAugust 29, 2019
FDA Product Classification

INGREDIENTS (4)

NORETHINDRONE ACETATEActive
Quantity: 5 mg in 1 1
Code: 9S44LIC7OJ
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Norethindrone acetate - FDA Drug Approval Details